List view / Grid view
26 September 2018 | By Mike Stones
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
24 September 2018 | By CPhI Worldwide
Record entries highlight a big year of innovation in pharma...
13 September 2018 | By Daniel Kracov, Jacqueline Mulryne, Libby Amos
As the UK prepares to withdraw from the EU on 29th March 2019 at 23:00, this article delivers a US perspective on what Brexit is likely to mean for pharmaceutical companies.
10 September 2018 | By Mike Stones
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
8 August 2018 | By SUEZ
The US FDA and European Commission have defined regulations relating to the submission of electronic records in lieu of paper documents, for submission, inspection, and archiving purposes. When ageing analytical equipment is to be replaced 21CFR Part 11 and EU Annex 11 are also topics of discussion. Common questions from…
7 August 2018 | By Mike Stones
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
7 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers found that more than one quarter (26 per cent) of patients taking Aimovig 70mg were migraine free after month 15...
19 July 2018 | By Dave P Elder, Mike Stones
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
9 May 2018 | By Reading Scientific Services Limited
Reading Scientific Services Ltd (RSSL) has appointed Katarzyna Szymaniec to lead its accredited pharmaceutical training business and align its strategic development with the diverse needs of professionals working within the sector...
1 March 2018 | By European Pharmaceutical Review
In this edition, two leading analytical equipment suppliers explain how their products meet current industry requirements.
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New permanent building to be completed by 15 November 2019...
8 January 2018 | By Allan Hillgrove - Boehringer Ingelheim
Allan Hillgrove, Member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit at Boehringer Ingelheim, tells EPR about some of his company’s achievements that he is most proud of, and describes how it will face the digital challenge...
8 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Following the Brexit vote, the UK is already seeing problems in filling senior positions at life sciences companies, with their average “slate” of candidates falling from around 40% non-UK nationals to just 15% non-UK candidates on average...
4 January 2018 | By Beatriz Faro - Pfizer
For Pfizer, putting patients first guides its actions, informs its strategic decisions and unifies colleagues in every region and function across the company. Beatriz Faro, Regional President, Internal Medicine, International Developed Markets at Pfizer, explains how the company’s philosophy is taking the business forward...
2 January 2018 | By Christof Hohne
Christof Hohne, partner at patent law firm EIP, discusses second medical use claims and compulsory licences...
Follow: